Residual disease after induction Therapy in Childhood ALL.: 'a highly significant prognostic factor'

被引：0
|
作者：
Cavé, H
ten Bosch, JV
Suciu, S
机构：
来源：
EUROPEAN JOURNAL OF CANCER | 1998年 / 34卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1989 / 1990
页数：2
相关论文
共 50 条
  • [1] Residual disease in childhood ALL - 'a highly significant prognostic factor' (vol 34, pg 1989, 1998)
    Cave, H
    ten Bosch, JV
    Suciu, S
    [J]. EUROPEAN JOURNAL OF CANCER, 1999, 35 (04) : 529 - 529
  • [2] Prognostic value of minimal residual disease in relapsed childhood ALL.
    Eckert, C
    Biondi, A
    Seeger, K
    Cazzaniga, G
    Hartmann, R
    Proba, J
    D'Aniello, E
    Beyermann, B
    Seifert, G
    Henze, G
    [J]. BLOOD, 2000, 96 (11) : 315A - 315A
  • [3] Quantification of minimal residual disease after BMT in ALL.
    Lausen, BF
    Petersen, SL
    Madsen, HO
    Ryder, L
    Heilmann, C
    Schmiegelow, K
    Vindelov, L
    Jacobsen, N
    [J]. BONE MARROW TRANSPLANTATION, 1999, 23 : S148 - S148
  • [4] Influence of post-induction treatment intensity on rates of minimal residual disease clearance in childhood ALL.
    Frost, L
    Wilson, G
    Goodeve, A
    Peake, I
    Vora, A
    [J]. BLOOD, 1998, 92 (10) : 394A - 394A
  • [5] In vitro drug resistance as important prognostic factor in two prospective studies in childhood all.
    Kaspers, GJL
    DenBoer, ML
    Pieters, R
    Janka, G
    VanWering, ER
    VanderdoesvandenBerg, A
    Veerman, AJP
    [J]. BLOOD, 1997, 90 (10) : 2521 - 2521
  • [6] Reemphasis on lymphoblast L2 morphology as a poor prognostic factor in childhood all.
    Kanerva, J
    SaarinenPihkala, UM
    Riikonen, P
    Makipernaa, A
    Mottonen, M
    Salmi, TT
    [J]. BLOOD, 1997, 90 (10) : 3702 - 3702
  • [7] p16INK4a immunocytochemical analysis is an independent prognostic factor in childhood ALL.
    Dalle, JH
    Fournier, M
    Nelken, B
    Mazingue, F
    Laï, JL
    Bauters, F
    Fenaux, P
    Quesnel, B
    [J]. BLOOD, 2001, 98 (11) : 314A - 314A
  • [8] In vitro resistance to prednisolone is related to minimal residual disease (MRD) after induction therapy in childhood acute lymphoblastic leukemia (ALL)
    de Haas, V
    Kaspers, GJL
    Oosten, L
    Bresters, D
    Wijkhuijs, AJM
    van den Berg, H
    van der Schoot, CE
    [J]. LEUKEMIA, 2001, 15 (03) : 510 - 510
  • [9] In vitro resistance to predulsolone is related to minimal residual disease (MRD) after induction therapy in childhood acute lymphoblastic leukemia (ALL)
    de Haas, V
    Kaspers, GJL
    Oosten, L
    Bresters, D
    Wijkhuijs, AJM
    van Wering, ER
    van den Berg, H
    van der Schoot, CE
    [J]. LEUKEMIA, 2001, 15 (12) : 2014 - 2015
  • [10] Intravenous PEG asparaginase during remission induction for childhood ALL.
    Silverman, Lewis B.
    Stevenson, Kristen
    Neuberg, Donna
    O'Brien, Jane
    Supko, Jeffrey
    Sallan, Stephen E.
    [J]. BLOOD, 2006, 108 (11) : 525A - 525A
12345